Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

Summary

The objective of this work is to investigate and then to sequence new biomarkers in the plasma of patients presenting with dyspnea secondary or not to heart failure, and study their diagnostic and prognostic value.

Conditions

• Heart Failure
• Dyspnea
• Pulmonary Disease

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris

  collaborator OTHER

• University Paris 7 - Denis Diderot

  collaborator OTHER

• ThermoFisher Scientific Brahms Biomarkers France

  collaborator INDUSTRY

• Hoffmann-La Roche

  collaborator INDUSTRY

• Alere San Diego

  collaborator INDUSTRY

• Servier

  collaborator INDUSTRY

• Helsinki University Central Hospital

  collaborator OTHER

• University Hospital, Basel, Switzerland

  collaborator OTHER

• Massachusetts General Hospital

  collaborator OTHER

• The Cleveland Clinic

  collaborator OTHER

• Maastricht University Medical Center

  collaborator OTHER

• Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria

  collaborator UNKNOWN

• Hospital Universitario Virgen de la Arrixaca

  collaborator OTHER

• University Hospital Monastir, Tunis

  collaborator OTHER

• Università degli Studi di Brescia

  collaborator OTHER

• Intensive and Cardiac Care Unit, Nippon Medical School, Tokyo, Japan

  collaborator UNKNOWN

• Brno University Hospital

  collaborator OTHER

• University of Cape Town

  collaborator OTHER

• Institut National de la Santé Et de la Recherche Médicale, France

  lead OTHER_GOV

Principal Investigators

• Alain Cohen-Solal, PHD · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-06-30

Primary Completion

2013-09-30

Completion

2014-01-31

Countries

• France

Study Locations